スポンサーリンク
Research Center Kyoto, Bayer Yakuhin, Ltd. | 論文
- Role of protein kinase A in the inhibition of human mast cell histamine release by β-adrenergic receptor agonists
- Effects of Luteolin, Quercetin and Baicalein on Immunoglobulin E-mediated Mediator Release from Human Cultured Mast Cells.
- Inhibition of Syk Activity and Degranulation of Human Mast Cells by Flavonoids (Pharmacology)
- Benzimidazole-5-sulfonamides as Novel Nonpeptide Luteinizing Hormone Releasing Hormone (LHRH) Antagonists : Minimization of Mechanism-Based CYP3A4 Inhibition
- IPD-1151T(Suplatast Tosilate)Inhibits Interleukin(IL)-13 Release but not IL-4 Release from Basophils.
- IPD-1151T (Suplatast Tosilate) Inhibits Interleukin (IL)-13 Release but Not IL-4 Release From Basophils
- Relationship between hitamine release and leukotrienes production from human basophils derived from atopic dermatitis donors.
- Pharmacological Modulation of LPS-induced MIP-1α Production by Perpheral Blood Mononuclear Cells.
- Pharmacological Modulation of LPS-Induced MIP-1α Production by Peripheral Blood Mononuclear Cells.
- Selective growth of human mast cells induced by Steel factor, IL-6 and prostaglandin E_2 from cord blood mononuclear cells.
- Role of Cyclic 3'5'-Adenosine Monophosphate in the Regulation of Chemical Mediator Release and Cytokine Production from Cultured Human Mast Cells.
- Ca^and Protein Kinase C Signaling for Histamine and Sulfidoleukotrienes Released from Human Cultured Mast Cells.
- The Effects of Anti-asthma Drugs on Mediator Release from Cultured Human Mast Cells.
- Cyclic AMP-elevating Agents Inhibit Mite-antigen-induced IL-4 and IL-3 Release from Basophil-enriched Leukocyte Preparation.